BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,219,000 | -18.3% | 21,291 | -21.3% | 0.03% | -6.5% |
| Q2 2022 | $3,941,000 | +37.3% | 27,045 | +11.7% | 0.03% | +82.4% |
| Q1 2022 | $2,871,000 | -14.6% | 24,219 | -0.7% | 0.02% | -5.6% |
| Q4 2021 | $3,362,000 | +27.9% | 24,398 | +28.9% | 0.02% | +12.5% |
| Q3 2021 | $2,628,000 | +12.5% | 18,921 | -21.3% | 0.02% | +14.3% |
| Q2 2021 | $2,335,000 | +21.6% | 24,052 | -14.4% | 0.01% | +7.7% |
| Q1 2021 | $1,920,000 | -13.1% | 28,095 | +9.0% | 0.01% | -7.1% |
| Q4 2020 | $2,210,000 | – | 25,783 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |